Skip to main content

Advertisement

Log in

Evaluation of the inhibitory effects of eckol and dieckol isolated from edible brown alga Eisenia bicyclis on human monoamine oxidases A and B

  • Research Article
  • Published:
Archives of Pharmacal Research Aims and scope Submit manuscript

Abstract

Eckol and dieckol are important phlorotannins found in edible brown algae including Eisenia bicyclis, Ecklonia stolonifera, and others. Inhibition of monoamine oxidase (MAO) play an important role in the early management of Parkinson’s disease (PD). The aim of this study was to determine the effectiveness of eckol and dieckol isolated from the methanolic extract of E. bicyclis against PD by the inhibition of human MAO-A and MAO-B (hMAO-A and hMAO-B). A sensitive enzyme-based chemiluminescent assay and kinetics methods were used to investigate enzyme inhibition and mode of inhibition. A molecular docking simulation was performed to clarify the binding characteristics of eckol and dieckol to hMAO-A and hMAO-B. The results suggested that methanolic extract of E. bicyclis and its isolated phlorotannins, eckol and dieckol, have potent inhibitory activity against hMAO-A and hMAO-B. The enzyme-based kinetics results demonstrated eckol mixed and non-competitive inhibition of hMAO-A and hMAO-B, respectively, while dieckol non-competitively inhibited both hMAOs. Molecular docking simulation predicted that eckol and dieckol exhibit higher binding affinity towards hMAO-A and hMAO-B through hydrogen bonding and hydrophobic interactions. These findings implicate eckol and dieckol as inhibitors of hMAOs that might be of potential value in the management of PD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+
from $39.99 /Month
  • Starting from 10 chapters or articles per month
  • Access and download chapters and articles from more than 300k books and 2,500 journals
  • Cancel anytime
View plans

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  • Abdullah R, Basak I, Patil KS, Alves G, Larsen JP, Moller G (2015) Parkinson’s disease and age: the obvious but largely unexplored link. Exp Gerontol 68:33–38

    Article  CAS  PubMed  Google Scholar 

  • Ahn BR, Moon HE, Kim HR, Jung HA, Choi JS (2012) Neuroprotective effect of edible brown alga Eisenia bicyclis on amyloid beta peptide-induced toxicity in PC12 cells. Arch Pharm Res 35:1989–1998

    Article  CAS  PubMed  Google Scholar 

  • Ali AEG (2010) Biological importance of marine algae. Saudi Pharm J 18:1–25

    Article  Google Scholar 

  • Bach AW, Lan NC, Johnson DL, Abell CW, Bembenek ME, Kwan SW, Seeburg PH, Shih JC (1988) cDNA cloning of human liver monoamine oxidase A and B: molecular basis of differences in enzymatic properties. Proc Natl Acad Sci USA 85:4934–4938

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bonnet U (2003) Moclobemide: therapeutic use and clinical studies. Drug Rev 9:97–140

    Article  CAS  Google Scholar 

  • Carta AR (2013) PPAR-γ: therapeutic prospects in Parkinson’s disease. Curr Drug Targets 14:743–751

    Article  CAS  PubMed  Google Scholar 

  • Da Prada M, Zurcher G, Wuthrich I, Haefely WE (1988) On tyramine, food, beverages and the reversible MAO inhibitor moclobemide. J Neural Transm Suppl 26:31–56

    PubMed  Google Scholar 

  • Fernandez HH, Chen JJ (2007) Monoamine oxidase-B inhibition in the treatment of Parkinson’s disease. Pharmacotherapy 27:174S–185S

    Article  CAS  PubMed  Google Scholar 

  • Finberg JP (2014) Update on the pharmacology of selective inhibitors of MAO-A and MAO-B: focus on modulation of CNS monoamine neurotransmitter release. Pharmacol Ther 143:133–152

    Article  CAS  PubMed  Google Scholar 

  • Finberg JP, Gillman K (2011) Selective inhibitors of monoamine oxidase type B and the “cheese effect”. Int Rev Neurobiol 100:169–190

    Article  CAS  PubMed  Google Scholar 

  • Flockhart DA (2012) Dietary restrictions and drug interactions with monoamine oxidase inhibitors: an update. J Clin Psychiatr 73:17–24

    Article  CAS  Google Scholar 

  • Friedman A, Arosio P, Finazzi D, Koziorowski D, Galazka-Friedman J (2011) Ferritin as an important player in neurodegeneration. Parkinsonism Relat Disord 17:423–430

    Article  PubMed  Google Scholar 

  • Fukuyama Y, Kodama M, Miura J, Kinzyo Z, Mori H, Nakayama Y, Takahashi M (1989) Structure of an anti-plasmin inhibitor, eckol, isolated from the brown alga Ecklonia kurome Okamura and inhibitory activities of its derivatives on plasma plasmin inhibitors. Chem Pharm Bull 37:349–353

    Article  CAS  PubMed  Google Scholar 

  • Goodsell DS, Morris GM, Olson AJ (1996) Automated docking of flexible ligands: applications of AutoDock. J Mol Recognit 9:1–5

    Article  CAS  PubMed  Google Scholar 

  • Hwang O (2013) Role of oxidative stress in Parkinson’s disease. Exp Neurobiol 22:11–17

    Article  PubMed  PubMed Central  Google Scholar 

  • Joe MJ, Kim SN, Choi HY, Shin WS, Park GM, Kang DW, Kim YK (2006) The inhibitory effects of eckol and dieckol from Ecklonia stolonifera on the expression of matrix metalloproteinase-I in human dermal fibroblasts. Biol Pharm Bull 29:1735–1739

    Article  CAS  PubMed  Google Scholar 

  • Jones G, Willett P, Glen RC, Leach AR, Taylor R (1997) Development and validation of a genetic algorithm for flexible docking. J Mol Biol 267:727–748

    Article  CAS  PubMed  Google Scholar 

  • Jung HA, Hyun SK, Kim HR, Choi JS (2006) Angiotensin-I converting enzyme inhibitory activity of phlorotannins from Ecklonia stolonifera. Fish Sci 72:1292–1299

    Article  CAS  Google Scholar 

  • Jung HA, Yoon NY, Woo MH, Choi JS (2008) Inhibitory activities of extracts from several kinds of seaweeds and phlorotannins from the brown alga Ecklonia stolonifera on glucose-mediated protein damage and rat lens aldose reductase. Fish Sci 74:1363–1365

    Article  CAS  Google Scholar 

  • Jung HA, Oh SH, Choi JS (2010) Molecular docking studies of phlorotannins from Eisenia bicyclis with BACE1 inhibitory activity. Bioorg Med Chem Lett 20:3211–3215

    Article  CAS  PubMed  Google Scholar 

  • Jung HA, Jin SE, Ahn BR, Lee CM, Choi JS (2013) Anti-inflammatory activity of edible brown alga Eisenia bicyclis and its constituents fucosterol and phlorotannins in LPS-stimulated RAW264.7 macrophages. Food Chem Toxicol 59:199–206

    Article  CAS  PubMed  Google Scholar 

  • Jung HA, Jung HJ, Jeong HY, Kwon HJ, Ali MY, Choi JS (2014) Phlorotannins isolated from the edible brown alga Ecklonia stolonifera exert anti-adipogenic activity on 3T3-L1 adipocytes by downregulating C/EBPα and PPARγ. Fitoterapia 92:260–269

    Article  CAS  PubMed  Google Scholar 

  • Kang HS, Chung HY, Jung JH, Son BW, Choi JS (2003) A new phlorotannin from the brown alga Ecklonia stolonifera. Chem Pharm Bull 51:1012–1014

    Article  CAS  PubMed  Google Scholar 

  • Kang HS, Kim HR, Byun DS, Son BW, Namg TJ, Choi JS (2004) Tyrosinase inhibitors isolated from the edible brown alga Ecklonia stolonifera. Arch Pharm Res 27:1226–1232

    Article  CAS  PubMed  Google Scholar 

  • Kang MC, Cha SH, Wijesinghe WA, Kang SM, Lee SH, Kim EA, Song CB, Jeon YJ (2013) Protective effect of marine alage phlorotannins against AAPH-induced oxidative stress in zebrafish embryo. Food Chem 138:950–955

    Article  CAS  PubMed  Google Scholar 

  • Kim YC, An RB, Yoon NY, Nam TJ, Choi JS (2005) Hepatoprotective constituents of the edible brown alga Ecklonia stolonifera on tacrine-induced cytotoxicity in Hep G2 cells. Arch Pharm Res 28:1376–1380

    Article  CAS  PubMed  Google Scholar 

  • Laskowski RA, Swindells MB (2011) LigPlot+: multiple ligand-protein interaction diagrams for drug discovery. J Chem Inf Model 51:2778–2786

    Article  CAS  PubMed  Google Scholar 

  • Lee SH, Park MH, Heo SJ, Kang SM, Ko SC, Han JS, Jeon YJ (2010) Dieckol isolated from Ecklonia cava inhibits a-glucosidase and a-amylase in vitro and alleviates postprandial hyperglycemia in streptozotocin-induced diabetic mice. Food Chem Toxicol 48:2633–2637

    Article  CAS  PubMed  Google Scholar 

  • Li Y, Qian ZJ, Ryu B, Lee SH, Kim MM, Kim SK (2009) Chemical components and its antioxidant properties in vitro: an edible marine brown alga, Ecklonia cava. Bioorg Med Chem 17:1963–1973

    Article  CAS  PubMed  Google Scholar 

  • Li YX, Wijesekara I, Li Y, Kim SK (2011) Phlorotannins as bioactive agents from brown algae. Process Biochem 46:2219–2224

    Article  CAS  Google Scholar 

  • Lin RD, Hou WC, Yen KY, Lee MH (2003) Inhibition of monoamine oxidase B (MAO-B) by Chinese herbal medicines. Phytomedicine 10:650–656

    Article  CAS  PubMed  Google Scholar 

  • Lum CT, Stahl SM (2012) Opportunities for reversible inhibitors of monoamine oxidase-A (RIMAs) in the treatment of depression. CNS Spectr 17:107–120

    Article  PubMed  Google Scholar 

  • Myung CS, Shin HC, Bao HY, Yeo SJ, Lee BH, Kang JS (2005) Improvement of memory by dieckol and phlorofucofuroeckol in ethanol-treated mice: possible involvement of the inhibition of acetylcholinesterase. Arch Pharm Res 28:691–698

    Article  CAS  PubMed  Google Scholar 

  • Nagayama K, Shibata T, Fujimoto K, Honjo H, Nakamura T (2003) Algicidal effect of phlorotannins from the brown alga Ecklonia kurome on red tide microalgae. Aquaculture 218:601–611

    Article  CAS  Google Scholar 

  • Nisizawa K, Noda H, Kikuchi R, Watanabe T (1987) The main seaweed foods in Japan. Hydrobiology 151:5–29

    Article  Google Scholar 

  • Noda H, Amano H, Arashima K, Hashimoto S, Nisizawa K (1989) Studies on the antitumor activity of marine algae. Nippon Suisan Gakk 55:1259–1264

    Article  Google Scholar 

  • Okada Y, Ishimaru A, Suzuki R, Okuyama T (2004) A new phloroglucinol derivative from the brown alga Eisenia bicyclis: potential for the effective treatment of diabetic complications. J Nat Prod 67:103–105

    Article  CAS  PubMed  Google Scholar 

  • Pae CU, Bodkin JA, Portland KB, Thase ME, Patkar AA (2012) Safety of selegiline transdermal system in clinical practice: analysis of adverse events from postmarketing exposures. J Clin Psychiatr 73:661–668

    Article  CAS  Google Scholar 

  • Provost JC, Funck-Brentano C, Rovei V, D’Estanque J, Ego D, Jaillon P (1992) Pharmacokinetic and pharmacodynamics interaction between toloxatone, a new reversible monoamine oxidase-A inhibitor, and oral tyramine in healthy subjects. Clin Pharmacol Ther 52:384–393

    Article  CAS  PubMed  Google Scholar 

  • Rarey M, Kramer B, Lengauer T, Klebe G (1996) A fast flexible docking method using an incremental construction algorithm. J Mol Biol 261:470–489

    Article  CAS  PubMed  Google Scholar 

  • Ryu B, Li Y, Qian ZJ, Kim MM, Kim SK (2009) Differentiation of human osteosarcoma cells by isolated phlorotannins is subtly linked to COX-2, iNOS, MMPs, and MAPK signaling: implication for chronic articular disease. Chem Biol Interact 179:192–201

    Article  CAS  PubMed  Google Scholar 

  • Schwartz TL (2013) A neuroscientific update on monoamine oxidase and its inhibitors. CNS Spectr 18:25–32

    Article  PubMed  Google Scholar 

  • Sturza A, Leisegang MS, Babelova A, Schroder K, Benkhoff S, Loot AE, Fleming I, Schulz R, Muntean DM, Brandes RP (2013) Monoamine oxidases are mediators of endothelial dysfunction in the mouse aorta. Hypertension 62:140–146

    Article  CAS  PubMed  Google Scholar 

  • Sugiura Y, Matsuda K, Yamada Y, Nishikawa M, Shioya K, Katsuzaki H, Imai K, Amano H (2006) Isolation of a new antiallergic phlorotannin, phlorofucofuroeckol-B, from an edible brown alga, Eisenia arborea. Biosci Biotechnol Biochem 70:2807–2811

    Article  CAS  PubMed  Google Scholar 

  • Valley MP, Zhou W, Hawkins EM, Shultz J, Cali JJ, Worzella T, Bernad L, Good T, Good D, Riss TL, Klaubert DH, Wood KV (2006) A bioluminescent assay for monoamine oxidase activity. Anal Biochem 359:238–246

    Article  CAS  PubMed  Google Scholar 

  • Yoon NY, Kim HR, Chung HY, Choi JS (2008) Anti-hyperlipidemic effect of an edible brown alga, Ecklonia stolonifera, and its constituents on poloxamer 407-induced hyperlipidemic and cholesterol-fed rats. Arch Pharm Res 31:1564–1571

    Article  CAS  PubMed  Google Scholar 

  • Youdim MB, Riederer PF (2007) Monoamine oxidase A and B inhibitors in Parkinson’s disease. Handb Clin Neurol 84:93–120

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education (2012R1A6A1028677).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jae Sue Choi.

Ethics declarations

Conflicts of interest

The authors declare no conflicts of interest.

Additional information

Hyun Ah Jung and Anupom Roys have contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jung, H.A., Roy, A., Jung, J.H. et al. Evaluation of the inhibitory effects of eckol and dieckol isolated from edible brown alga Eisenia bicyclis on human monoamine oxidases A and B. Arch. Pharm. Res. 40, 480–491 (2017). https://doi.org/10.1007/s12272-017-0904-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12272-017-0904-3

Keywords